首页> 外文OA文献 >Relation Between Clinical, Angiographic and Ischemic Findings at Baseline and Ischemia-Related Adverse Outcomes at 1 Year in the Asymptomatic Cardiac Ischemia Pilot Studyfn1This study was funded by the National Heart, Lung, and Blood Institute, Cardiac Diseases Branch, Division of Heart and Vascular Diseases, National Institutes of Health, Bethesda, Maryland, by Research Contracts HV-90-07, HV90-08, HV-91-05 to HV-91-14. Study medications and placebo were donated by Zeneca Pharmaceuticals Group, Wilmington, Delaware; Marion-Merrell Dow, Kansas City, Missouri; and Pfizer, New York, New York. Support for electrocardiographic data collection was provided in part by Applied Cardiac Systems, Laguna Hills, California; Marquette Electronics, Milwaukee, Wisconsin; Mortara Instrument, Milwaukee, Wisconsin; and Quinton Instruments, Seattle, Washington. Some centers had partial support from grants from the General Clinical Research Center, National Institutes of Health.
【2h】

Relation Between Clinical, Angiographic and Ischemic Findings at Baseline and Ischemia-Related Adverse Outcomes at 1 Year in the Asymptomatic Cardiac Ischemia Pilot Studyfn1This study was funded by the National Heart, Lung, and Blood Institute, Cardiac Diseases Branch, Division of Heart and Vascular Diseases, National Institutes of Health, Bethesda, Maryland, by Research Contracts HV-90-07, HV90-08, HV-91-05 to HV-91-14. Study medications and placebo were donated by Zeneca Pharmaceuticals Group, Wilmington, Delaware; Marion-Merrell Dow, Kansas City, Missouri; and Pfizer, New York, New York. Support for electrocardiographic data collection was provided in part by Applied Cardiac Systems, Laguna Hills, California; Marquette Electronics, Milwaukee, Wisconsin; Mortara Instrument, Milwaukee, Wisconsin; and Quinton Instruments, Seattle, Washington. Some centers had partial support from grants from the General Clinical Research Center, National Institutes of Health.

机译:无症状性心脏缺血性先导研究在基线时的临床,血管造影和缺血性发现与1年时与缺血相关的不良结果之间的关系本研究由美国国家心脏病,肺和血液研究所,心脏疾病和血管病科心脏疾病分会资助,位于美国马里兰州贝塞斯达(Bethesda)的美国国立卫生研究院(National Institutes of Health),依据研究合同HV-90-07,HV90-08,HV-91-05至HV-91-14。研究药物和安慰剂由特拉华州威明顿市的Zeneca制药集团捐赠;密苏里州堪萨斯城的Marion-Merrell Dow;辉瑞公司,纽约,纽约。加州拉古纳山的Applied Cardiac Systems部分提供了对心电图数据收集的支持。威斯康星州密尔沃基市的Marquette Electronics;威斯康星州密尔沃基的Mortara Instrument公司;昆顿仪器公司,华盛顿州西雅图市。一些中心得到了美国国立卫生研究院普通​​临床研究中心的部分资助。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Journal of the American College of Cardiology 29 (1997) 1483-1489. doi:10.1016/S0735-1097(97)00083-1
机译:美国心脏病学会杂志29(1997)1483-1489。 doi:10.1016 / S0735-1097(97)00083-1

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号